mab221 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
90
Structured Review
R&D Systems
mab221
Mab221, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab221/Human+PDGF-AA+Antibody/pm36482075-203-110-116
Average 90 stars, based on 4 article reviews
Mab221, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab221/Human+PDGF-AA+Antibody/pm36482075-203-110-116
Average 90 stars, based on 4 article reviews
mab221 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Concentration Assay:Article Title: Controlled release of growth factors using synthetic glycosaminoglycans in a modular macroporous scaffold for tissue regeneration. Article Snippet: For the screening, the proteins; HGF (294-HG-025/CF, RnD systems), VEGF (293-VE-010/CF, RnD systems), BMP4 (314-BP-010/CF, RnD systems) CXCL12, (350-NS-010/CF, RnD systems), IL-6 (7270-IL-025/CF, RnD systems), FGF2 (ab9596, Abcam), PDGF-AA (221-AA-010, RnD systems), KGF (251-KG010/CF, RnD systems), and TGF beta 1 (7754-BH-025/CF, RnD systems) were dissolved at a concentration of 10 μg/ml in PBS (1891014, Thermo Fisher), Tween 20 (P1379, Sigma-Aldrich,) and 10% BSA (A2153, Sigma-Aldrich), and 100 μl of the solution was added to the slide and incubated in a humified chamber for 60 min. .. The slides were rinsed in PBST with 1% BSA for 3 min and then in deionized water for 3 min. Antibodies towards the protein were dissolved in PBST 10% BSA according to the manufacturer’s recommended concentration, added to the slide and incubated in a humified chamber for 60 min (HGF Ab, MAB694, 0.4 μg/ml, Mouse anti Human, RnD systems) (VEGF Ab, MAB293, 0.4 μg/ml, Mouse anti Human, RnD systems) (BMP4 Ab, MAB7571, 0.4 μg/ml, Mouse anti Human, RnD systems) (CXCL12 Ab, MAB350, 0.4 μg/ml, Mouse ant Human, RnD Systems) (IL-6 Ab, MAB2063, 0.4 μg/ml, Mouse ant Human, RnD systems) (FGF2 Ab, ab92337, 0.5 μg/ml, Rabbit anti Human, Abcam) (PDGF-AA Ab, Article Title: Controlled release of growth factors using synthetic glycosaminoglycans in a modular macroporous scaffold for tissue regeneration Article Snippet: For the screening, the proteins; HGF (294-HG-025/CF, RnD systems), VEGF (293-VE-010/CF, RnD systems), BMP4 (314-BP-010/CF, RnD systems) CXCL12, (350-NS-010/CF, RnD systems), IL-6 (7270-IL-025/CF, RnD systems), FGF2 (ab9596, Abcam), PDGF-AA (221-AA-010, RnD systems), KGF (251-KG-010/CF, RnD systems), and TGF beta 1 (7754-BH-025/CF, RnD systems) were dissolved at a concentration of 10 μg/ml in PBS (1891014, Thermo Fisher), Tween 20 (P1379, Sigma-Aldrich,) and 10% BSA (A2153, Sigma-Aldrich), and 100 μl of the solution was added to the slide and incubated in a humified chamber for 60 min. .. The slides were rinsed in PBST with 1% BSA for 3 min and then in deionized water for 3 min. Antibodies towards the protein were dissolved in PBST 10% BSA according to the manufacturer’s recommended concentration, added to the slide and incubated in a humified chamber for 60 min (HGF Ab, MAB694, 0.4 μg/ml, Mouse anti Human, RnD systems) (VEGF Ab, MAB293, 0.4 μg/ml, Mouse anti Human, RnD systems) (BMP4 Ab, MAB7571, 0.4 μg/ml, Mouse anti Human, RnD systems) (CXCL12 Ab, MAB350, 0.4 μg/ml, Mouse ant Human, RnD Systems) (IL-6 Ab, MAB2063, 0.4 μg/ml, Mouse ant Human, RnD systems) (FGF2 Ab, ab92337, 0.5 μg/ml, Rabbit anti Human, Abcam) (PDGF-AA Ab, Incubation:Article Title: Controlled release of growth factors using synthetic glycosaminoglycans in a modular macroporous scaffold for tissue regeneration. Article Snippet: For the screening, the proteins; HGF (294-HG-025/CF, RnD systems), VEGF (293-VE-010/CF, RnD systems), BMP4 (314-BP-010/CF, RnD systems) CXCL12, (350-NS-010/CF, RnD systems), IL-6 (7270-IL-025/CF, RnD systems), FGF2 (ab9596, Abcam), PDGF-AA (221-AA-010, RnD systems), KGF (251-KG010/CF, RnD systems), and TGF beta 1 (7754-BH-025/CF, RnD systems) were dissolved at a concentration of 10 μg/ml in PBS (1891014, Thermo Fisher), Tween 20 (P1379, Sigma-Aldrich,) and 10% BSA (A2153, Sigma-Aldrich), and 100 μl of the solution was added to the slide and incubated in a humified chamber for 60 min. .. The slides were rinsed in PBST with 1% BSA for 3 min and then in deionized water for 3 min. Antibodies towards the protein were dissolved in PBST 10% BSA according to the manufacturer’s recommended concentration, added to the slide and incubated in a humified chamber for 60 min (HGF Ab, MAB694, 0.4 μg/ml, Mouse anti Human, RnD systems) (VEGF Ab, MAB293, 0.4 μg/ml, Mouse anti Human, RnD systems) (BMP4 Ab, MAB7571, 0.4 μg/ml, Mouse anti Human, RnD systems) (CXCL12 Ab, MAB350, 0.4 μg/ml, Mouse ant Human, RnD Systems) (IL-6 Ab, MAB2063, 0.4 μg/ml, Mouse ant Human, RnD systems) (FGF2 Ab, ab92337, 0.5 μg/ml, Rabbit anti Human, Abcam) (PDGF-AA Ab, Article Title: Controlled release of growth factors using synthetic glycosaminoglycans in a modular macroporous scaffold for tissue regeneration Article Snippet: For the screening, the proteins; HGF (294-HG-025/CF, RnD systems), VEGF (293-VE-010/CF, RnD systems), BMP4 (314-BP-010/CF, RnD systems) CXCL12, (350-NS-010/CF, RnD systems), IL-6 (7270-IL-025/CF, RnD systems), FGF2 (ab9596, Abcam), PDGF-AA (221-AA-010, RnD systems), KGF (251-KG-010/CF, RnD systems), and TGF beta 1 (7754-BH-025/CF, RnD systems) were dissolved at a concentration of 10 μg/ml in PBS (1891014, Thermo Fisher), Tween 20 (P1379, Sigma-Aldrich,) and 10% BSA (A2153, Sigma-Aldrich), and 100 μl of the solution was added to the slide and incubated in a humified chamber for 60 min. .. The slides were rinsed in PBST with 1% BSA for 3 min and then in deionized water for 3 min. Antibodies towards the protein were dissolved in PBST 10% BSA according to the manufacturer’s recommended concentration, added to the slide and incubated in a humified chamber for 60 min (HGF Ab, MAB694, 0.4 μg/ml, Mouse anti Human, RnD systems) (VEGF Ab, MAB293, 0.4 μg/ml, Mouse anti Human, RnD systems) (BMP4 Ab, MAB7571, 0.4 μg/ml, Mouse anti Human, RnD systems) (CXCL12 Ab, MAB350, 0.4 μg/ml, Mouse ant Human, RnD Systems) (IL-6 Ab, MAB2063, 0.4 μg/ml, Mouse ant Human, RnD systems) (FGF2 Ab, ab92337, 0.5 μg/ml, Rabbit anti Human, Abcam) (PDGF-AA Ab, |